Compare REPL & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REPL | CCNE |
|---|---|---|
| Founded | 2015 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 721.7M | 736.3M |
| IPO Year | 2018 | N/A |
| Metric | REPL | CCNE |
|---|---|---|
| Price | $10.04 | $27.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $12.00 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 1.7M | 125.0K |
| Earning Date | 11-06-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | N/A | ★ $227,923,000.00 |
| Revenue This Year | N/A | $13.84 |
| Revenue Next Year | N/A | $27.68 |
| P/E Ratio | ★ N/A | $14.60 |
| Revenue Growth | N/A | ★ 5.27 |
| 52 Week Low | $2.68 | $19.32 |
| 52 Week High | $14.80 | $28.00 |
| Indicator | REPL | CCNE |
|---|---|---|
| Relative Strength Index (RSI) | 57.68 | 72.27 |
| Support Level | $9.63 | $27.53 |
| Resistance Level | $10.29 | $27.19 |
| Average True Range (ATR) | 0.59 | 0.51 |
| MACD | -0.10 | 0.16 |
| Stochastic Oscillator | 35.42 | 89.04 |
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.